163 related articles for article (PubMed ID: 26467701)
1. Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma.
Smith E; Palethorpe HM; Ruszkiewicz AR; Edwards S; Leach DA; Underwood TJ; Need EF; Drew PA
Dig Dis Sci; 2016 Feb; 61(2):433-43. PubMed ID: 26467701
[TBL] [Abstract][Full Text] [Related]
2. Androgen Signaling in Esophageal Adenocarcinoma Cell Lines In Vitro.
Palethorpe HM; Drew PA; Smith E
Dig Dis Sci; 2017 Dec; 62(12):3402-3414. PubMed ID: 29052817
[TBL] [Abstract][Full Text] [Related]
3. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus.
Tihan T; Harmon JW; Wan X; Younes Z; Nass P; Duncan KL; Duncan MD
Anticancer Res; 2001; 21(4B):3107-14. PubMed ID: 11712819
[TBL] [Abstract][Full Text] [Related]
4. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
[TBL] [Abstract][Full Text] [Related]
5. Androgens and esophageal cancer: What do we know?
Sukocheva OA; Li B; Due SL; Hussey DJ; Watson DI
World J Gastroenterol; 2015 May; 21(20):6146-56. PubMed ID: 26034350
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel androgen receptor target genes in prostate cancer.
Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
[TBL] [Abstract][Full Text] [Related]
7. Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element.
Magee JA; Chang LW; Stormo GD; Milbrandt J
Endocrinology; 2006 Jan; 147(1):590-8. PubMed ID: 16210365
[TBL] [Abstract][Full Text] [Related]
8. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.
Periyasamy S; Hinds T; Shemshedini L; Shou W; Sanchez ER
Oncogene; 2010 Mar; 29(11):1691-701. PubMed ID: 20023700
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response.
Sun NK; Huang SL; Chang PY; Lu HP; Chao CC
Oncotarget; 2014 Dec; 5(23):11939-56. PubMed ID: 25460502
[TBL] [Abstract][Full Text] [Related]
10. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
11. Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.
Hess-Wilson JK; Webb SL; Daly HK; Leung YK; Boldison J; Comstock CE; Sartor MA; Ho SM; Knudsen KE
Environ Health Perspect; 2007 Nov; 115(11):1646-53. PubMed ID: 18007998
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity.
Chaurasiya S; Widmann S; Botero C; Lin CY; Gustafsson JÅ; Strom AM
PLoS One; 2020; 15(5):e0226057. PubMed ID: 32413024
[TBL] [Abstract][Full Text] [Related]
13. Androgens stimulate erythropoiesis through the DNA-binding activity of the androgen receptor in non-hematopoietic cells.
McManus JF; Nguyen NN; Davey RA; MacLean HE; Pomilio G; McCormack MP; Chiu WS; Wei AH; Zajac JD; Curtis DJ
Eur J Haematol; 2020 Sep; 105(3):247-254. PubMed ID: 32311143
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.
Leach DA; Trotta AP; Need EF; Risbridger GP; Taylor RA; Buchanan G
Prostate; 2017 Feb; 77(2):185-195. PubMed ID: 27718274
[TBL] [Abstract][Full Text] [Related]
15. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
[TBL] [Abstract][Full Text] [Related]
16. Modeling truncated AR expression in a natural androgen responsive environment and identification of RHOB as a direct transcriptional target.
Tsai HC; Boucher DL; Martinez A; Tepper CG; Kung HJ
PLoS One; 2012; 7(11):e49887. PubMed ID: 23209612
[TBL] [Abstract][Full Text] [Related]
17. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
[TBL] [Abstract][Full Text] [Related]
18. Androgenic modulation of AR-Vs.
Hillebrand AC; Pizzolato LS; Branchini G; Brum IS
Endocrine; 2018 Nov; 62(2):477-486. PubMed ID: 30027434
[TBL] [Abstract][Full Text] [Related]
19. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.
Mostaghel EA; Morgan A; Zhang X; Marck BT; Xia J; Hunter-Merrill R; Gulati R; Plymate S; Vessella RL; Corey E; Higano CS; Matsumoto AM; Montgomery RB; Nelson PS
PLoS One; 2014; 9(10):e111545. PubMed ID: 25356728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]